GALNT7 and prostate cancer: Recently, GALNT7 was identified as a single gene effector of cell surface glycosylation and glycocalyx height [23], suggesting that GALNT7 mediated O-glycosylation might act at the interface of cellular signalling processes in prostate cancer and play an important role in disease progression.